Impact of Metformin on Cancer Biomarkers in Non-Diabetic Cancer Patients: A Systematic Review and Meta-Analysis of Clinical Trials

Introduction: Our aim was to investigate and evaluate the influence of metformin on cancer-related biomarkers in clinical trials. Methods: This systematic study was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Major databases, includi...

Descripción completa

Detalles Bibliográficos
Autores principales: Farkhondeh, Tahereh, Amirabadizadeh, Alireza, Aramjoo, Hamed, Llorens, Silvia, Roshanravan, Babak, Saeedi, Farhad, Talebi, Marjan, Shakibaei, Mehdi, Samarghandian, Saeed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167716/
https://www.ncbi.nlm.nih.gov/pubmed/33917520
http://dx.doi.org/10.3390/curroncol28020134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167716/
https://www.ncbi.nlm.nih.gov/pubmed/33917520
http://dx.doi.org/10.3390/curroncol28020134

Ejemplares similares